ALNYLAM PHARMACEUTICALS, INC. Unrecognized Tax Benefits
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Unrecognized Tax Benefits of $77.97 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-12
- 2025-12-31: Unrecognized Tax Benefits $77.97M.
- 2024-12-31: Unrecognized Tax Benefits $59.37M; Unrecognized Tax Benefits as first filed $53.10M.
- 2023-12-31: Unrecognized Tax Benefits $0.00.
- 2019-12-31: Unrecognized Tax Benefits $305.00K.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $77.97M 10-K · filed 2026-02-12 | |
| 2024-12-31 | $59.37M 10-K · filed 2026-02-12 | $53.10M 10-K · filed 2025-02-13 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-12 | |
| 2019-12-31 | $305.00K 10-K · filed 2020-02-13 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-13 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-13 | |
| 2011-12-31 | $128.00K 10-K · filed 2014-02-20 | |
| 2010-12-31 | $428.00K 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |